We observed that animals receiving Nintedanib in early stages of tumor growth displayed a significant decrease in the newly formed vessel density, although animals treated with the drug later in angiogenesis also displayed a substantial decrease in Nestin expression. This evidence concerns the gene NES and neoplasm.